Oscar Health entered into a secured revolving credit facility to support general corporate purposes. The $475 million facility, expandable by up to $100 million, matures on February 6, 2029, and includes customary covenants and financial tests. Borrowings initially accrue interest at Term SOFR plus 4.50% or the Alternate Base Rate plus 3.50%, with margins and commitment fees adjusting based on leverage metrics after June 30, 2026. Management expects the facility to enhance liquidity and financial flexibility.
Agreement details:
- Agreement type: Secured three-year revolving credit facility ($475 million, expandable by $100 million)
- Counterparty: JPMorgan Chase Bank, as Administrative Agent, and other lenders
- Signed / Effective: Feb 06 2026 / Feb 06 2026
- Duration / Termination: 3 years
- Reason: Enhance liquidity for general corporate purposes
Original SEC Filing: Oscar Health, Inc. [ OSCR ] – 8-K – Feb. 10, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Source: tradingview.com
